Overview
Anxiety disorders during pregnancy involve heightened levels of anxiety that can impact maternal physiological processes, potentially affecting fetal homeostasis through sympathetic nervous system hyperactivity 1.Diagnosis
Symptoms include excessive worry, restlessness, irritability, and sleep disturbances 1.
No specific diagnostic tests; clinical assessment and standardized screening tools (e.g., GAD-7) are recommended 1.
Grading severity based on symptomatology and impact on daily functioning 1.Management
First-line treatments: Cognitive Behavioral Therapy (CBT) and mindfulness-based interventions 1.
Pharmacological options: Selective Serotonin Reuptake Inhibitors (SSRIs) like sertraline at standard doses may be considered, though evidence is limited in pregnancy 1.
Non-pharmacological: Relaxation techniques, support groups, and psychoeducation 1.Special Populations
Pregnancy: Anxiety can affect fetal development; close monitoring and tailored interventions are crucial 1.
Comorbidities: Women with pre-existing anxiety disorders or other mental health conditions may require more intensive management 1.Key Recommendations
Screen pregnant women for anxiety using validated tools to identify those at risk 1 (Evidence: Moderate).
Prioritize non-pharmacological interventions such as CBT and mindfulness for managing anxiety during pregnancy 1 (Evidence: Moderate).
Consider SSRIs like sertraline cautiously in severe cases, weighing risks and benefits with close fetal monitoring 1 (Evidence: Weak).References
1 Ascher BH. Maternal anxiety in pregnancy and fetal homeostasis. JOGN nursing; journal of obstetric, gynecologic, and neonatal nursing 1978. link